🇺🇸 FDA
Pipeline program

Lidocaine HCl

1720150047

Phase 2 small_molecule active

Quick answer

Lidocaine HCl for Postherpetic Neuralgia is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Postherpetic Neuralgia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials